Global Intravenous Immunoglobulin (IVIg) Market: Global Market Size, Trends, Competitive, Historical & Forecast Analysis, 2019-2025

Report ID: BMRC 82 | Number of pages: 192 | Publish Date: Jul 2019 | Publisher: BMRC | Category: Lifesciences and Healthcare
Our final report will cover impact analysis of COVID-19 outbreak
New
Global Intravenous Immunoglobulin Market is valued at USD 9804.8 Million in 2018 and expected to reach USD 16587.0 Million by 2025 with the CAGR of 7.80% over the forecast period. Growing geriatric population, rising prevalence of immunodeficiency diseases, increasing adoption of IVIG treatments and rising use of off-label indications are the key drivers of the Global Intravenous Immunoglobulin Market.

Scope of Global Intravenous Immunoglobulin Market Report–

Intravenous Immunoglobulin (IVIg), a compound comprising of immune proteins (globulins) is administered into the bloodstream to treat patients with inefficient or damaged immune systems. IVIg provides the required antibodies to the human body to fight out the immune deficiency, and the ensuing infectious attacks. Immunoglobulin also referred as antibodies, are the glycoprotein molecules manufactured by the plasma or white blood cells. Immunoglobulin’s form a very critical line of defense of the immune system by specially recognizing and binding itself to particular antigens such as bacteria and viruses and aid in their destruction. In certain individual, immunoglobulins have to be administered for the treatment and management of disease such as primary immunodeficiency (PI). Intravenous immunoglobulins are the most popular form of immunoglobulin due to the no requirement for self-administration and the easy administration in hospital and clinic settings. Different classes of immunoglobulin such as IgA, IgG, and IgM are used for the treatment of various neurological and immunological diseases. Global Intravenous Immunoglobulin market report is segmented on the basis of type, application, end-users and region & country level. Based on type, global intravenous immunoglobulin market is classified into IgG, IgA, IgM, IgE and IgD. Based on application global intravenous immunoglobulin market is classified into hypogammaglobulinemia, immunodeficiency diseases, congenital AIDS, chronic inflammatory demyelinating polyneuropathy, myasthenia gravis, multifocal motor neuropathy, ITP, Guillain-Barre syndrome, Kawasaki Diseases and others. Based on end-user, global intravenous immunoglobulin market is classified into hospitals, clinics, homecare and others. The regions covered in this intravenous immunoglobulin market report are North America, Europe, Asia-Pacific and Rest of the World. On the basis of country level, market of intravenous immunoglobulin is sub divided into U.S., Mexico, Canada, U.K., France, Germany, Italy, China, Japan, India, South East Asia, GCC, Africa, etc. Key Players for Global Intravenous Immunoglobulin Market Report- Global intravenous immunoglobulin market report covers prominent players like Omrix Biopharmaceuticals Ltd., Hualan Biological Engineering Inc., Shanghai RAAS Blood Products Co. Ltd., Behring GmbH, Option Care Enterprises, Inc., BioScrip, Inc, ADMA Biologics, Inc., CSL Ltd., Baxter International Inc., Kedrion Biopharma Inc., Grifols S.A, LFB group, Octapharma AG, ADMA Biologics, Inc., China Biologics Products, Inc., Biotest AG, Takeda Pharmaceuticals and among others. Global Intravenous Immunoglobulin Market Dynamics– Rising elderly population, increasing occurrence of immunodeficiency disorders, growing implementation of IVIG procedures and increasing usage of off-label indications are some of the major factors driving the market growth. Increasing number of patients with immunodeficiency disease is the primary reason for the expansion of IVIG procedures. According to the World Health Organization (WHO), there are approximately 50 diverse Primary Immune Deficiency (PID) such as X-lined hypo-gamma-globulinemia, specific antibody deficiency and others. Furthermore, according to the U.S. National Library of Medicine and National Institute of Health, around 6 million patients are suffering from Primary Immune Deficiency (PID) globally. Rising occurrences of these immune diseases is expected to foster the demand for intravenous immunoglobulin treatments during the forecast period. However, stringent government regulations regarding the use of intravenous immunoglobulin products and high risk of side effects associated with them are expected to hinder the growth of the market. Moreover, high adoption of intravenous immunoglobulins for the treatment of various diseases is expected to create lucrative opportunities in the near future. Geographically, this report split global into several key Regions, revenue (Million USD) The geography (North America, Europe, Asia-Pacific, Latin America and Middle East & Africa) focusing on key countries in each region. It also covers market drivers, restraints, opportunities, challenges, and key issues in Global Intravenous Immunoglobulin (IVIg) Market. Key Benefits for Intravenous Immunoglobulin (IVIg) Market Reports • Global market report covers in-depth historical and forecast analysis. • Global market research report provides detail information about Market Introduction, Market Summary, Global market Revenue (Revenue USD), Market Drivers, Market Restraints, Market Opportunities, Competitive Analysis, Regional and Country Level. • Global market report helps to identify opportunities in market place. • Global market report covers extensive analysis of emerging trends and competitive landscape.

Global Intravenous Immunoglobulin Market Segmentation:–

By Type: • IgG • IgA • IgM • IgE • IgD By Application: • Hypogammaglobulinemia • Immunodeficiency Diseases • Congenital AIDS • Chronic Inflammatory Demyelinating Polyneuropathy • Myasthenia Gravis • Multifocal Motor Neuropathy • ITP • Guillain-Barre syndrome • Kawasaki Diseases • Others By End-Users: • Hospitals • Clinics • Homecare • Others By Region • North America o U.S. o Canada o Mexico • Europe o UK o France o Germany o Russia o Rest of Europe • Asia-Pacific o China o South Korea o India o Japan o Rest of Asia-Pacific • LAMEA o Latin America o Middle East o Africa Global Intravenous Immunoglobulin Market Regional Analysis– North America is expected to dominate the global intravenous immunoglobulin market. Increasing healthcare expenditure, growing level of consciousness for the products involved in the treatment of immunodeficiency disorders, and rising inclination of clinicians towards immunodeficiency therapies are the key factors attributing towards the market growth. Additionally, growing occurrences of primary immunodeficiency (PID) is also expected to enhance the market growth in this region. According to American Autoimmune Related Disease Association Inc. (AARDA) 2012, approximately 50 million Americans were diagnosed to have autoimmune diseases and the number of people suffering this disease. Asia Pacific is expected to show a significant growth at a considerable CAGR over forecast period owing to the increasing awareness and potential opportunities for adoption of immunoglobulin based therapies for the treatment of primary immune deficiencies coupled with growing geriatric population in this region. Intravenous Immunoglobulin (IVIg) Market Key Players: • Bharat Serums and Vaccines Limited • Biotest AG • China Biologic Products, Inc. • Guizhou Taibang Biological Products Co., Ltd • CSL Limited • Grifols, S.A. • Hualan Biological Engineering Inc. • Kedrion S.p.A. • LFB Group • Octapharma AG • Others This comprehensive report will provide: • Enhance your strategic decision making • Assist with your research, presentations and business plans • Show which emerging market opportunities to focus on • Increase your industry knowledge • Keep you up-to-date with crucial market developments • Allow you to develop informed growth strategies • Build your technical insight • Illustrate trends to exploit • Strengthen your analysis of competitors • Provide risk analysis, helping you avoid the pitfalls other companies could make • Ultimately, help you to maximize profitability for your company. Our Market Research Solution Provides You Answer to Below Mentioned Question: • Which are the driving factors responsible for the growth of market? • Which are the roadblock factors of this market? • What are the new opportunities, by which market will grow in coming years? • What are the trends of this market? • Which are main factors responsible for new product launch? • How big is the global & regional market in terms of revenue, sales and production? • How far will the market grow in forecast period in terms of revenue, sales and production? • Which region is dominating the global market and what are the market shares of each region in the overall market in 2017? • How will each segment grow over the forecast period and how much revenue will these segment account for in 2025? • Which region has more opportunities?
Interested in this report?
Get your sample now!
Table of Content
1. Chapter - Report Methodology
1.1. Research Process 
1.2. Primary Research 
1.3. Secondary Research
1.4. Market Size Estimates
1.5. Data Triangulation
1.6. Forecast Model 
1.7. USP’s of Report 
1.8. Report Description 
2. Chapter – Global Intravenous Immunoglobulin (IVIg) Market Overview: Qualitative Analysis
2.1. Market Introduction
2.2. Executive Summary 
2.3. Global Intravenous Immunoglobulin (IVIg) Market Classification
2.4. Market Drivers
2.5. Market Restraints
2.6. Market Opportunity
2.7. Intravenous Immunoglobulin (IVIg) Market: Trends
2.8. Porter’s Five Forces Analysis
2.8.1. Bargaining Power of Suppliers
2.8.2. Bargaining Power of Consumers
2.8.3. Threat of New Entrants
2.8.4. Threat of Substitute Product and Services
2.8.5. Competitive Rivalry within the Industry
2.9. Market Attractiveness Analysis 
2.9.1. Market Attractiveness Analysis by Segmentation 
2.9.2. Market Attractiveness Analysis by Region 
3. Chapter - Global Intravenous Immunoglobulin (IVIg) Market Overview: Quantitative Analysis
3.1. Global Intravenous Immunoglobulin (IVIg) Market Revenue (USD Million), Market Share (%) and Growth Rate (%), 2014- 2025
3.2. Global Intravenous Immunoglobulin (IVIg) Market Revenue Market Share (%), 2014- 2025
3.3. Global Intravenous Immunoglobulin (IVIg) Market Sales (Number of Units), Market Share (%) and Growth Rate (%), 2014- 2025
3.4. Global Intravenous Immunoglobulin (IVIg) Market Sales Market Share (%), 2014- 2025
4. Chapter – Global Intravenous Immunoglobulin (IVIg) Market Analysis: By Type
5. Chapter – Global Intravenous Immunoglobulin (IVIg) Market Analysis: By Application
6. Chapter - Global Intravenous Immunoglobulin (IVIg) Market Analysis: By Manufacturer 
6.1. Global Intravenous Immunoglobulin (IVIg) Market Revenue (USD Million), by Manufacturer, 2014 - 2025
6.2. Global Intravenous Immunoglobulin (IVIg) Market Share (%), by Manufacturer, 2018
6.3. Global Intravenous Immunoglobulin (IVIg) Market Sales (Number of Units), by Manufacturer, 2014 - 2025
6.4. Global Intravenous Immunoglobulin (IVIg) Market Share (%), by Manufacturer, 2018
6.5. Global Intravenous Immunoglobulin (IVIg) Market Price (USD/Unit), by Manufacturer, 2014 - 2025
6.6. Global Intravenous Immunoglobulin (IVIg) Market Revenue Growth Rate (%), by Manufacturer, 2014 – 2025
6.7. Merger & Acquisition
6.8. Collaborations and Partnership
6.9. New Product Launch
7. Chapter –Intravenous Immunoglobulin (IVIg) Market: Regional Analysis
7.1. North America
7.1.1. North America Intravenous Immunoglobulin (IVIg) Market Revenue (USD Million) and Growth Rate (%), 2014 – 2025.
7.1.2. North America Intravenous Immunoglobulin (IVIg) Market Revenue (USD Million) By Country, 2014 – 2025.
7.1.3. North America Intravenous Immunoglobulin (IVIg) Revenue Market Share (%) By Country, 2014 – 2025.
7.1.4. North America Intravenous Immunoglobulin (IVIg) Market Revenue (USD Million) and Growth Rate, By Market Segmentation, 2014 – 2025.
7.1.5. North America Intravenous Immunoglobulin (IVIg) Market Revenue (USD Million), Market Share (%) and Growth Rate, By Market Segmentation, 2014 – 2025.
7.1.6. North America Intravenous Immunoglobulin (IVIg) Market Sales (Number of Units) and Growth Rate (%), 2014 – 2025.
7.1.7. North America Intravenous Immunoglobulin (IVIg) Market Sales (Number of Units) By Country, 2014 – 2025.
7.1.8. North America Intravenous Immunoglobulin (IVIg) Sales Market Share (%) By Country, 2014 – 2025.
7.1.9. North America Intravenous Immunoglobulin (IVIg) Market Sales (Number of Units) and Growth Rate, By Market Segmentation, 2014 – 2025.
7.1.10. North America Intravenous Immunoglobulin (IVIg) Market Sales (Number of Units), Market Share (%) and Growth Rate, By Market Segmentation, 2014 – 2025.
7.2. Europe
7.3. Asia Pacific
7.4. Latin America
7.5. Middle East & Africa
8. Chapter - Company Profiles
8.1. Bharat Serums and Vaccines Limited 
8.1.1. Overview
8.1.2. Financials
8.1.3. Product portfolio
8.1.4. Intravenous Immunoglobulin (IVIg) Market Revenue (USD Million) and Market Share (%), 2014 - 2018
8.1.5. Intravenous Immunoglobulin (IVIg) Sales Market Share (%), 2014 - 2018
8.1.6. Business strategy
8.1.7. Recent developments
8.2. Biotest AG
8.3. China Biologic Products, Inc. 
8.4. Guizhou Taibang Biological Products Co., Ltd 
8.5. CSL Limited 
8.6. Grifols, S.A. 
8.7. Hualan Biological Engineering Inc. 
8.8. Kedrion S.p.A. 
8.9. LFB Group 
8.10. Octapharma AG 
8.11. Shanghai RAAS Blood Products Co., Ltd. 
8.12. Shire plc 
8.13. Sichuan Yuanda Shuyang Pharmaceutical Co., Ltd 
8.14. Others
9. Chapter – Market Research and Findings


This free Sample Report is purely a representation of our full report, for evaluating the market scope/data and make informed purchase decisions.